Clinical Trial Update: Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy study of AS101 for elderly patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• AS101

Snippet

Sponsor: BioMAS Ltd | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 2 | Status: SUSPENDED